Expression of bcl-2 and Epstein-Barr virus LMP1 in lymphocytic interstitial pneumonia

Thorax

Volumn 52, Issue 1, 1997, Pages 12-16

  Kaan, Philomena M ^a   Hegele, Richard G ^a   Hayashi, Shizu ^a   Hogg, James C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

B cell leukemia 2 gene; Epstein Barr virus; lymphocytic interstitial pneumonia

Indexed keywords

ALKALINE PHOSPHATASE; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LUNG FIBROSIS; LYMPHOID CELL; PRIORITY JOURNAL; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION;

EID: 0031022153     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.52.1.12     Document Type: Article

References (31)

1. Carrington CB, Liebow AA. Lymphocytic interstitial pneumonia. Am J Pathol 1966;48:36.
2. Andiman WA, Martin K, Rubinstein A, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985;ii: 1390-3.
3. Barberà JA, Hayashi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992;145: 940-6.
4. Katz BZ, Berkman AB, Shapiro ED. Serologic evidence of active Epstein-Barr virus infection in Epstein-Barr virus-associated lymphoproliferative disorders of children with acquired immunodeficiency syndrome. J Pediatr 1992; 120:228-32.
5. Kramer MJ, Saldana MJ, Ramos M, Pitchenik AE. High titers of Epsrein-Barr virus antibodies in adult patients with lymphocytic interstitial pneumonitis associated with AIDS. Respir Med 1992;86:49-52.
6. Zutter M, Hockenbery D, Silverman GA, Korsmeyer SJ. Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 1991;78:1062-8.
7. Mariano MT, Moretti L, Donelli A, et al. Bcl-2 gene expression in hematopoietic cell differentiation. Blood 1992; 80:768-75.
8. Merino R, Ding L, Veis DJ, Korsmeyer SJ, Nunez G. Developmental regulation of the bcl-2 protein and susceptibility to cell death in B lymphocyte. EMBO J 1994; 13:683-91.
9. Nunez G, Hockenbery D, McDonnell J, Sorensen CM, Korsmeyer SJ. Bcl-2 maintains B cell memory. Nature 1991;353:71-3.
10. Liu YJ, Mason DY, Johnson GD, et al. Germinal center cells express bcl-2 protein alter activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991; 21:1905-10.
11. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-86.
12. Wang F, Gregory CD, Sample C, et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypie changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23. J Virol 1990;64:2309-18.
13. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991;349:612-4.
14. Finke J, Fritzen R, Ternes P, et al. Expression of bcl-2 in Burkitt's lymphoma cell lines: induction by latent membrane Epstein-Barr virus genes. Blood 1992;80:459-69.
15. Lawrence JB, Villnave CA, Singer RH. Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation ot two closely integrated copies of EBV in a lymphoma line. Cell 1988;52:51-61.
16. Cattoretti G, Stefano P, Parravicini C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993;171:83-98.
17. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complex). J Histochem Cytochem 1984;32:219-29.
18. Bolender RP, Hyde DM, Dehoff RT. Lung morphometry: a new generation of tools and experiments for organ, tissue, cell, and molecular biology. Am J Physiol (Lung Cell Mol Physiol) 1993;265:L521-48.
19. Conover WJ. Measures of dependence. In: Practical non-parametric statistics. New York: McGraw-Hill, 1988.
20. Zar JH. The binomial distribution. In: Biostatistical analysis. New Jersey: Prentice-Hall, 1984:400-2.
21. Holland BS, Copenhaver MD. An improved sequentially rejective Bonferroni test procedure. Biometrics 1987;43: 417-23.
22. Lung ML, Lam WK, So SY, Lam WP, Chan KH, Ng MH. Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1985;i:889-92.
23. Egan JJ, Stewart JP, Hasledton PS, Arrand JR, Carroll KB, Woodcock AA. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 1995;50:1234-9.
24. Rocchi G, DeFelici A, Ragona G, Heinz A. Quantitative evaluation of Epstein-Barr virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 1977;296:132.
25. Rowe M, Peng-Pilon M, Huen DS, et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell specific response that is delayed relative to NF-KB activation and to induction of cell surface markers, J Virol 1994;68:5602-12.
26. Straus SE, Cohen JI, Tosato G, Meier J. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 1993;118:45-58.
27. Niedobitek G, Young LS. Epstein-Barr visu persistence and virus-associated tumors. Lancet 1994;343:333-5.
28. Rowe M, Rowe DT, Gregory CD, et al. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J 1987;6:2743-51.
29. Gregory CD, Rowe M, Rickinson AB. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J Gen Virol 1990; 71:1481-95.
30. Tao Q, Srivastava G, Loke SL, Ho FCS. Lack of correlation between expression of Epstein-Barr virus (HBV) latent membrane protein and bcl-2 oncoprotein in vivo. J Clin Pathol 1994;47:589-91.
31. Schlaifer D, Brousset P, Attal M, et al. bcl-2 proto-oncogene and Epstein-Barr virus latent membrane protein-1 expression in AIDS-related lymphoma. Histopathology 1994; 25:77-82.